SOURCE: IBC Life Sciences

March 30, 2006 10:30 ET

Achieving 5 g/L and Beyond Covered at IBC's Cell Line Development and Engineering Conference

WESTBOROUGH, MA -- (MARKET WIRE) -- March 30, 2006 -- IBC's Cell Line Development and Engineering conference focuses on maximizing expression levels to meet the industry's demand for therapeutic antibody production.

This conference to be held on June 26-28, 2006 in San Diego, CA, delivers the latest advances occurring during every stage of the process from molecular biology through manufacturing. The event presents success stories from Centocor, Lonza Biologics plc, MedImmune, and PDL BioPharma on how to increase therapeutic antibodies through total process optimization.

Now in its second year, this event brings together an unrivalled speaker assembly from academia and the biopharmaceutical industry. Malla Padidam, Director of Stem Cell Therapeutics at Rheogene, Inc., past attendee states, "This conference offers great coverage of topics related directly to cell line development -- A real practical value to people working in this area."

The format is a mixture of 41 presentations, including 2 panel discussions, an industry keynote address by David K. Robinson, Executive Director, Therapeutic Protein Commercialization, Bioprocess R&D, of Merck Research Laboratories and academic keynotes addresses by Michael J. Betenbaugh, Ph.D., Professor and Chair, Chemical and Biomolecular Engineering of Johns Hopkins University and Florian Maria Wurm, Ph.D., Professor of Biotechnology, Swiss Federal Institute of Technology Lausanne (EPFL), Switzerland.

Topics include high-titer production, optimizing efficiency and productivity, engineering host cells, high throughput screening techniques, alternative expression systems, regulatory considerations and many more.

This year, a comprehensive 3-day format was developed to provide in-depth coverage on utilizing platform technologies, using RNAi to improve production yields, comparisons of alternative expression systems, and end-user evaluations of testing methodologies.

For complete information on the program, visit: http://www.IBCLifeSciences.com/B3189

To obtain a press pass for this event or to arrange an interview with a speaker, contact Heather Teepe at (508) 614-1494.

IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. To develop its programs, IBC actively researches the advancements, technologies and trends impacting and driving the race for new drugs and therapies. No other organization can make claim to the breadth and quality that IBC Life Sciences delivers in each event giving the company recognition around the globe for quality, service and value.

http://www.IBCLifeSciences.com

Contact Information